Zydus Lifesciences gets USFDA nod for acne treatment gel

The final approval by the US Food and Drug Administration (USFDA) is for Dapsone gel of strength 7.5 per cent, Zydus Lifesciences said in a regulatory filing.

PTI

May 09, 2024 / 13:23 IST

Zydus Lifesciences gets USFDA nod for acne treatment gel

Zydus Lifesciences Ltd on Thursday said it has received final approval from the US health regulator to market its generic version of Dapsone gel used to treat acne.

The final approval by the US Food and Drug Administration (USFDA) is for Dapsone gel of strength 7.5 per cent, Zydus Lifesciences said in a regulatory filing.

Dapsone gel is used to treat acne and will be manufactured at the group's topical manufacturing facility in Changodar, Ahmedabad, it added.

Dapsone gel, 7.5 per cent had annual sales of USD 35.8 million in the US, Zydus Lifesciences said citing IQVIA MAT March 2024 data.

PTI

first published: May 9, 2024 01:23 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347